Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2018

Industry: 

890 Views
Buy This Report

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. 

  • 890 reads